Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Change in Taxes: 2021-2022

Historic Change in Taxes for Cartesian Therapeutics (RNAC) over the last 1 years, with Sep 2022 value amounting to -$321,000.

  • Cartesian Therapeutics' Change in Taxes fell 102.03% to -$321,000 in Q3 2022 from the same period last year, while for Sep 2022 it was -$15.8 million, marking a year-over-year change of. This contributed to the annual value of -$601,000 for FY2022, which is 200.00% down from last year.
  • Latest data reveals that Cartesian Therapeutics reported Change in Taxes of -$321,000 as of Q3 2022, which was down 32,200.00% from $1,000 recorded in Q2 2022.
  • Cartesian Therapeutics' Change in Taxes' 5-year high stood at $15.8 million during Q3 2021, with a 5-year trough of -$15.2 million in Q4 2021.
  • Over the past 2 years, Cartesian Therapeutics' median Change in Taxes value was -$281,000 (recorded in 2022), while the average stood at $0.
  • Data for Cartesian Therapeutics' Change in Taxes shows a maximum YoY plummeted of 102.03% (in 2022) over the last 5 years.
  • Over the past 2 years, Cartesian Therapeutics' Change in Taxes (Quarterly) stood at -$15.2 million in 2021, then slumped by 102.03% to -$321,000 in 2022.
  • Its Change in Taxes stands at -$321,000 for Q3 2022, versus $1,000 for Q2 2022 and -$281,000 for Q1 2022.